MENU
+Compare
COO
Stock ticker: NASDAQ
AS OF
Oct 15, 11:16 AM (EDT)
Price
$70.41
Change
-$0.80 (-1.12%)
Capitalization
14.16B

COO stock forecast, quote, news & analysis

CooperCompanies is one of the largest eyecare companies in the US... Show more

COO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. COO showed earnings on August 27, 2025. You can read more about the earnings report here.
Interact to see
Advertisement
A.I.Advisor
a Summary for COO with price predictions
Oct 14, 2025

COO in -2.69% downward trend, declining for three consecutive days on October 10, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where COO declined for three days, in of 315 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 62 cases where COO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 26, 2025. You may want to consider a long position or call options on COO as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for COO just turned positive on September 19, 2025. Looking at past instances where COO's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

COO moved above its 50-day moving average on October 14, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for COO crossed bullishly above the 50-day moving average on October 14, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where COO advanced for three days, in of 294 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. COO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.695) is normal, around the industry mean (10.739). P/E Ratio (34.907) is within average values for comparable stocks, (54.868). Projected Growth (PEG Ratio) (0.894) is also within normal values, averaging (1.742). COO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (3.531) is also within normal values, averaging (13.726).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. COO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

A.I.Advisor
published Dividends

COO paid dividends on August 11, 2023

Cooper Companies (The) COO Stock Dividends
А dividend of $0.03 per share was paid with a record date of August 11, 2023, and an ex-dividend date of July 26, 2023. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Intuitive Surgical (NASDAQ:ISRG), Align Technology (NASDAQ:ALGN).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 10.95B. The market cap for tickers in the group ranges from 246 to 156.44B. ISRG holds the highest valuation in this group at 156.44B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was -3%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was 15%. TGLVY experienced the highest price growth at 36%, while ECIA experienced the biggest fall at -42%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was -12%. For the same stocks of the Industry, the average monthly volume growth was -57% and the average quarterly volume growth was -11%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 56
P/E Growth Rating: 64
Price Growth Rating: 59
SMR Rating: 81
Profit Risk Rating: 92
Seasonality Score: 18 (-100 ... +100)
View a ticker or compare two or three
COO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a maker of medical devices

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
6101 Bollinger Canyon Road
Phone
+1 925 460-3600
Employees
15000
Web
https://www.coopercos.com